HVTN 702

HVTN 702 was a clinical trial which the HIV Vaccine Trials Network organized to develop an HIV vaccine. In February 2020 the organizers halted the trial after finding no evidence of efficacy.[1][2][3]

Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV.[4][5]

In 2016 various media outlets announced the start of the research.[6][7][8]

HVTN 702 was based on outcomes of the RV 144 trial.[9]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.